 |
|
Dual Inhibition of PI3K/Akt/mTOR Pathway and Role of Autophagy in Non-Small Cell Lung Cancer Cells
Eun-Hui Jeong, Hyeong Sim Choi, Tae-Gul Lee, Hye-Ryoun Kim, Cheol Hyeon Kim
Tuberc Respir Dis. 2012;72(4):343-351. Published online 2012 Apr 30 DOI: https://doi.org/10.4046/trd.2012.72.4.343
|
|
Citations to this article as recorded by
 Targeting autophagy in disease: established and new strategies
Muhammed Kocak, Saba Ezazi Erdi, Guillem Jorba, Inés Maestro, Judith Farrés, Vladimir Kirkin, Ana Martinez, Ole Pless
Autophagy.2022; 18(3): 473. CrossRef Advances in autophagy as a target in the treatment of tumours
Yingying Li, Shan Gao, Xiyou Du, Jianbo Ji, Yanwei Xi, Guangxi Zhai
Journal of Drug Targeting.2022; 30(2): 166. CrossRef AKT inhibition sensitizes EVI1 expressing colon cancer cells to irinotecan therapy by regulating the Akt/mTOR axis
Pradeepa, Voddu Suresh, Shantibhusan Senapati, Soumen Chakraborty
Cellular Oncology.2022; 45(4): 659. CrossRef Treating non-small cell lung cancer by targeting the PI3K signaling pathway
Lin Jiang, Jingbo Zhang, Yan Xu, Heng Xu, Mengzhao Wang
Chinese Medical Journal.2022; 135(11): 1272. CrossRef Identification of Clinical Candidate M2698, a Dual p70S6K and Akt Inhibitor, for Treatment of PAM Pathway-Altered Cancers
Lizbeth DeSelm, Bayard Huck, Ruoxi Lan, Constantin Neagu, Justin Potnick, Yufang Xiao, Xiaoling Chen, Reinaldo Jones, Thomas E. Richardson, Brian H. Heasley, Thomas Haxell, Joseph Moore, Hui Tian, Katrin Georgi, Felix Rohdich, Amanda Sutton, Theresa Johns
Journal of Medicinal Chemistry.2021; 64(19): 14603. CrossRef Novel PI3K/Akt/mTOR pathway inhibitors plus radiotherapy: Strategy for non-small cell lung cancer with mutant RAS gene
Kai Chen, Zhongjun Shang, Ai-lin Dai, Pei-ling Dai
Life Sciences.2020; 255: 117816. CrossRef Role of the PI3K‑mTOR autophagy pathway in nerve damage in rats with intermittent hypoxia‑aggravated whole brain ischemia
Xia Guo, Yao Liu, Yaning Zhao, Rong Fan, Yali Bai, Xiangfei Guo, Jianmin Li, Changxiang Chen
Molecular Medicine Reports.2019;[Epub] CrossRef Allicin activates autophagic cell death to alleviate the malignant development of thyroid cancer
Yangfeng Xiang, Jianqiang Zhao, Ming Zhao, Kejing Wang
Experimental and Therapeutic Medicine.2018;[Epub] CrossRef Gambogic acid improves non‐small cell lung cancer progression by inhibition of mTOR signaling pathway
Teng Zhao, Hong‐Jian Wang, Wen‐Wen Zhao, Yi‐Ling Sun, Li‐Kuan Hu
The Kaohsiung Journal of Medical Sciences.2017; 33(11): 543. CrossRef Targeting autophagy to modulate cell survival: a comparative analysis in cancer, normal and embryonic cells
Aleksandra Divac Rankov, Mila Ljujić, Marija Petrić, Dragica Radojković, Milica Pešić, Jelena Dinić
Histochemistry and Cell Biology.2017; 148(5): 529. CrossRef Keratinization of Lung Squamous Cell Carcinoma Is Associated with Poor Clinical Outcome
Hye Jung Park, Yoon-Jin Cha, Seong Han Kim, Arum Kim, Eun Young Kim, Yoon Soo Chang
Tuberculosis and Respiratory Diseases.2017; 80(2): 179. CrossRef Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer
Guangbo Liu, Fen Pei, Fengqing Yang, Lingxiao Li, Amit Amin, Songnian Liu, J. Buchan, William Cho
International Journal of Molecular Sciences.2017; 18(2): 367. CrossRef Therapeutic targeting of autophagy in cancer. Part II: Pharmacological modulation of treatment-induced autophagy
Anika Nagelkerke, Johan Bussink, Anneke Geurts-Moespot, Fred C.G.J. Sweep, Paul N. Span
Seminars in Cancer Biology.2015; 31: 99. CrossRef Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells
Ki-Eun Hwang, Young-Suk Kim, Jae-Wan Jung, Su-Jin Kwon, Do-Sim Park, Byong-Ki Cha, Seon-Hee Oh, Kwon-Ha Yoon, Eun-Taik Jeong, Hak-Ryul Kim
Oncotarget.2015; 6(30): 29482. CrossRef Temsirolimus improves cytotoxic efficacy of cisplatin and gemcitabine against urinary bladder cancer cell lines
Rosário Pinto-Leite, Regina Arantes-Rodrigues, Rita Ferreira, Carlos Palmeira, Aura Colaço, Vítor Moreira da Silva, Paula Oliveira, Lúcio Lara Santos
Urologic Oncology: Seminars and Original Investigations.2014; 32(1): 41.e11. CrossRef Endothelial dysfunction
Zhen Chen, Marcy Martin, Zhao Li, John Y-J. Shyy
Current Opinion in Lipidology.2014; 25(5): 339. CrossRef Ampelopsin suppresses breast carcinogenesis by inhibiting the mTOR signalling pathway
Hui Chang, Xiaoli Peng, Qian Bai, Yong Zhou, Xiaoping Yu, Qianyong Zhang, Jundong Zhu, Mantian Mi
Carcinogenesis.2014; 35(8): 1847. CrossRef Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer
Claudia Fumarola, Mara A. Bonelli, Pier Giorgio Petronini, Roberta R. Alfieri
Biochemical Pharmacology.2014; 90(3): 197. CrossRef Targeting mTOR to Overcome Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance in Non-Small Cell Lung Cancer Cells
Shi-Jiang Fei, Xu-Chao Zhang, Song Dong, Hua Cheng, Yi-Fang Zhang, Ling Huang, Hai-Yu Zhou, Zhi Xie, Zhi-Hong Chen, Yi-Long Wu, Jingwu Xie
PLoS ONE.2013; 8(7): e69104. CrossRef Cell survival and metastasis regulation by Akt signaling in colorectal cancer
Ekta Agarwal, Michael G. Brattain, Sanjib Chowdhury
Cellular Signalling.2013; 25(8): 1711. CrossRef
|